Written by Artificial intelligence has emerged as one of the most disruptive technologies in modern healthcare, particularly within the field of gastrointestinal endoscopy. Traditionally, endoscopic procedures relied heavily on the expertise and experience of physicians, making diagnostic accuracy susceptible to human limitations such as fatigue, missed lesions, and variability in interpretation. AI-powered technologies are overcoming these challenges by integrating computer vision, machine learning, and deep learning algorithms into endoscopic systems, enabling real-time image analysis, lesion detection, disease classification, and procedural guidance.
👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85264
Modern AI platforms primarily function through Computer-Aided Detection (CADe) and Computer-Aided Diagnosis (CADx) technologies. CADe solutions assist physicians by automatically highlighting suspicious lesions or polyps during endoscopic examinations, whereas CADx systems analyze detected abnormalities and provide diagnostic insights regarding their pathological characteristics. These innovations are significantly improving adenoma detection rates, enhancing colorectal cancer screening, and supporting early disease intervention. As healthcare systems increasingly adopt precision medicine and digital diagnostics, AI-enabled endoscopy is becoming an essential component of next-generation gastrointestinal care.
Market Size and Growth
The global AI in Endoscopy Market generated US$ 39.5 million in revenue in 2021 and is forecast to exceed US$ 421.8 million by 2031, reflecting an exceptional 26.9% CAGR throughout the forecast period. This rapid growth is driven by the increasing prevalence of gastrointestinal disorders, rising colorectal cancer incidence, expanding adoption of minimally invasive procedures, and continuous technological advancements in AI-assisted diagnostic platforms.
One of the strongest market growth drivers is the growing burden of colorectal cancer worldwide. According to the World Health Organization (WHO), approximately 1.9 million new colorectal cancer cases and nearly 935,000 deaths were reported in 2020, making early detection a critical healthcare priority. AI-assisted colonoscopy significantly improves polyp detection and characterization, enabling clinicians to identify precancerous lesions that might otherwise remain undetected. Furthermore, continuous product launches, FDA approvals, and favorable reimbursement policies are encouraging healthcare providers to integrate AI-powered endoscopy systems into routine clinical practice.
Market Segmentation
By Type
The market is segmented into Products and Services, with products accounting for the larger revenue share owing to increasing installations of AI-integrated endoscopy platforms in hospitals and specialty clinics. Continuous software upgrades and cloud-based AI solutions are also creating new opportunities for service providers.
By Technology
Based on technology, the market includes CAD, CADx, CADe, and CADe/CADx integrated systems. Among these, the CADe segment dominated the global market in 2021. AI-powered CADe platforms utilize advanced computer vision algorithms to identify suspicious tissue in real time, improving adenoma detection rates during colonoscopy procedures. FDA-approved solutions such as GI Genius and EndoScreener have demonstrated strong clinical performance, encouraging widespread adoption among healthcare providers.
CADx systems are also gaining momentum as they help physicians differentiate between benign and malignant lesions, improving diagnostic confidence while reducing unnecessary biopsies and treatment delays.
By End User
Hospitals represented the largest end-user segment due to their advanced infrastructure, availability of specialized gastroenterologists, favorable reimbursement frameworks, and increasing patient preference for comprehensive gastrointestinal treatment. Ambulatory Surgical Centers are also witnessing growing adoption as outpatient minimally invasive procedures become increasingly popular across developed healthcare systems.
Regional Analysis
North America currently represents one of the largest markets for AI in endoscopy due to its advanced healthcare infrastructure, high adoption of AI-enabled medical technologies, supportive reimbursement systems, and frequent FDA approvals. The United States remains the primary revenue contributor owing to increasing colorectal cancer screening programs and strong investments in digital healthcare innovation.
Europe also maintains a significant market share supported by widespread awareness regarding early cancer detection, favorable government initiatives, and rising adoption of AI-assisted diagnostic technologies across Germany, the United Kingdom, France, Italy, and Spain.
Asia Pacific is expected to register the fastest growth during the forecast period. Rapid healthcare infrastructure development, increasing healthcare expenditure, expanding aging population, and rising gastrointestinal disease prevalence across China, India, and Japan are creating substantial market opportunities. Government investments in digital health initiatives and collaborations between global medical technology companies and regional healthcare institutions are expected to accelerate AI adoption throughout the region.
Latin America and the Middle East & Africa are also anticipated to experience steady growth as healthcare modernization initiatives and access to advanced diagnostic technologies continue to improve.
Competitive Landscape
The global AI in Endoscopy Market remains highly consolidated, with several multinational corporations and innovative AI startups competing through product innovation, regulatory approvals, strategic partnerships, acquisitions, and geographical expansion.
Major market participants include Medtronic, Wision A.I., Olympus Corporation, Fujifilm Corporation, Pentax Corporation, NEC Corporation, Odin Vision, Magentiq Eye Ltd., Wuhan EndoAngel Medical Technology Company, and Iterative Scopes.
Recent strategic developments continue to shape the competitive environment. Medtronic introduced its AI-powered GI Genius Module to enhance colorectal cancer detection during colonoscopy procedures. Iterative Scopes secured FDA clearance for SKOUT, enabling real-time computer-assisted polyp detection. Olympus expanded its AI diagnostic initiatives through collaborations with government organizations and research institutions, while Wision A.I. strengthened its portfolio following FDA clearance for EndoScreener. Partnerships among Virgo, Satisfai Health, and Alimentiv further demonstrate the growing emphasis on integrating AI into clinical research and inflammatory bowel disease management.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Media Contact:Â
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453